Diagnosis of human herpesvirus 6(HHV-6)-associated infection after hematopoietic stem cell transplantation.
Project/Area Number |
22790954
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Infectious disease medicine
|
Research Institution | Kochi University |
Principal Investigator |
TANIGUCHI Ayuko 高知大学, 教育研究部・医療学系, 助教 (30403885)
|
Project Period (FY) |
2010 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | ウイルス学 / 感染症学 / ヘルペスウイルス / 染色体 / ヒトヘルペスウイルス6 / ヘルペスウイルス感染症 |
Research Abstract |
Human herpesvirus 6(HHV-6) infection is recognized as a potentially life-threatening condition affecting hematopoietic stem cell transplantation recipients due to reactivation of the virus from a latent state. For example, HHV-6 can cause acute encephalitis in imunocompromised patients. However, HHV-6 is unique among human herpesviruses because of its ability into chromosomes of the host cells. This entity, termed chromosomally integrated HHV-6(CIHHV-6), has the potential to confound the diagnosis of active HHV-6 infection, since chromosomally integrated HHV-6 DNA sequences are inherited through the germline. Therefore, CIHHV-6 should be distinguishable from acute HHV-6 infection. In all CIHHV-6 cases studied, fluorescence in situ hybridization showed that HHV-6 DNA colocalized with telomeric regions of one allele on chromosomes. It is important to exclude CIHHV-6 before concluding that there is evidence of active HHV-6 infection.
|
Report
(3 results)
Research Products
(14 results)